![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:7777Y Cambridge Antibody Tech Group PLC 18 May 2004 CORRECTION - Cambridge Antibody Interim results RNS Number: 7271Y Cambridge Antibody Tech Group PLC 17 May 2004 In the statement of Cambridge Antibody Technology Group's interim results for the six months ended 31 March 2004 issued at 7.00 am UK time on 17 May 2004, the weighted average number of shares for the six months ended 31 March 2004 should have read 40,638,511 rather than 42,913,700. Accordingly, the loss per share for the six months ended 31 March 2004 should have read 44.2 pence rather than 41.9 pence. For Further Information Contact: Cambridge Antibody Technology Tel: +44 (0) 1223 471 471 Rowena Gardner, Director of Corporate Communications END This information is provided by RNS The company news service from the London Stock Exchange END IR DGGDUXUBGGSR
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions